PatientBond joins Upfront to become the market-leading, personalized patient access and engagement platform.  Read press release

Request a Demo
Watch Overview

Justin Dearborn Recognized as Most Influential CEO 2022 by CEO Monthly

CEO Monthly logo

CEO Monthly recognized Justin Dearborn, CEO of PatientBond, as "The Most Influential CEO 2022 - the USA" for leading the company at the forefront of transformation in healthcare and patient engagement in the digital age. PatientBond's platform, which integrates a proprietary psychographic segmentation model with dynamic, multi-channel digital workflows, has consistently demonstrated that it can personalize patient engagement to motivate and activate positive health behaviors across patient and insurance member populations.

By leveraging healthcare consumer insights and innovative technology solutions, PatientBond has played a crucial role in building tighter bonds between patients and medical teams.

"We can scale individualized, personalized engagement across any size population, which is a significant competitive advantage," explains Mr. Dearborn. "We help our customers improve health outcomes by closing clinical care gaps, reducing unnecessary hospital readmissions and promoting healthy and preventative behaviors."

Dearborn states that PatientBond's vision is to be the industry leader in activating positive and desired healthcare consumer behaviors using its combination of psychographic insights and innovative technology solutions. Psychographics pertain to people's attitudes, beliefs, values and personalities and are core to their motivations, priorities and communication preferences. Harnessing these insights enables PatientBond to help healthcare providers connect with patients beyond the walls of the doctor's office with communications that truly resonate with each individual patient and activate the appropriate behaviors. This gives PatientBond an edge versus other patient engagement technology companies.

PatientBond offers a suite of services to enhance clinical, marketing and Revenue Cycle Management efforts among hospitals & health systems, health insurance companies, urgent care, life sciences and industry partners. Some of the results PatientBond has helped clients achieve include:

  • Up to 85% reduction in hospital readmissions for congestive heart failure and COPD (chronic obstructive pulmonary disease)
  • Up to 7X increase in patient response to initiatives for closing gaps in care
  • Double response rate to marketing and patient acquisition campaigns
  • 400 percent increase in patient financial responsibility payments with up to 50% decrease in paper statement costs

Dearborn adds, "For the third year in a row, we have achieved an industry-leading 80+ Net Promoter Score among our customers when the average IT company NPS is only 33." PatientBond has also been recognized as part of The Financial Times list of The Americas' Fastest Growing Companies 2022. This prestigious award is presented by The Financial Times and Statista Inc., the world-leading statistics portal and industry ranking provider. This is the third year in a row that PatientBond has achieved this recognition.

Click here to read the CEO Monthly article on Justin Dearborn and PatientBond.

Submit a Comment

Request a Demo